<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Alder Scores Deal With Bristol-Myers Potentially Worth $1 Billion</title>
	<atom:link href="http://www.xconomy.com/seattle/2009/11/10/alder-scores-partnership-with-bristol-myers-potentially-worth-1-billion/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/seattle/2009/11/10/alder-scores-partnership-with-bristol-myers-potentially-worth-1-billion/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sat, 11 Feb 2012 03:54:18 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.4</generator>
	<item>
		<title>By: Rheumatoid Arthritis Blogs</title>
		<link>http://www.xconomy.com/seattle/2009/11/10/alder-scores-partnership-with-bristol-myers-potentially-worth-1-billion/comment-page-1/#comment-171065</link>
		<dc:creator>Rheumatoid Arthritis Blogs</dc:creator>
		<pubDate>Fri, 16 Jul 2010 01:24:59 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=49806#comment-171065</guid>
		<description>Bristol has partnered with someone else recently too, correct? Let&#039;s hope good things come about this. I&#039;m tired of all the pain :-(</description>
		<content:encoded><![CDATA[<p>Bristol has partnered with someone else recently too, correct? Let’s hope good things come about this. I’m tired of all the pain :-(</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Alliance struck between Bristol-Myers Squibb and Alder Biopharmaceuticals worth US$1 billion &#171; Silico Research</title>
		<link>http://www.xconomy.com/seattle/2009/11/10/alder-scores-partnership-with-bristol-myers-potentially-worth-1-billion/comment-page-1/#comment-91866</link>
		<dc:creator>Alliance struck between Bristol-Myers Squibb and Alder Biopharmaceuticals worth US$1 billion &#171; Silico Research</dc:creator>
		<pubDate>Thu, 12 Nov 2009 12:53:10 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=49806#comment-91866</guid>
		<description>[...] 11 2009 Alder Biopharmaceuticals, a Seattle-based biotechnology company specialising in antibodies struck a deal with Bristol-Myers Squibb that could be worth more than $1 billion. At present this stands [...]</description>
		<content:encoded><![CDATA[<p>[...] 11 2009 Alder Biopharmaceuticals, a Seattle-based biotechnology company specialising in antibodies struck a deal with Bristol-Myers Squibb that could be worth more than $1 billion. At present this stands [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

